Mark Chin Harpoon Therapeutics, Inc. (HARP) insider trading activity

Mark Chin is of Harpoon Therapeutics, Inc.. Currently has a direct ownership of 0 shares of HARP, which is worth approximately $0. The most recent transaction as insider was on Mar 11, 2024, when has been sold 13,224 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

0% 3M change

100.0% 12M change

Total Value Held $0

Mark Chin Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 11 2024	SELL Sale (or disposition) back to the issuer	-	13,224 Reduced 100.0%	0 Common Stock
Mar 08 2024	BUY Grant, award, or other acquisition	-	424 Added 3.11%	13,224 Common Stock
Jan 01 2024	BUY Grant, award, or other acquisition	-	1,072 Added 7.73%	12,801 Common Stock
Nov 27 2023	BUY Grant, award, or other acquisition	-	5,000 Added 29.89%	11,729 Common Stock
Oct 01 2023	BUY Grant, award, or other acquisition	-	3,035 Added 31.08%	6,729 Common Stock
Jul 01 2023	BUY Grant, award, or other acquisition	-	18,656 Added 33.56%	36,941 Common Stock
Apr 01 2023	BUY Grant, award, or other acquisition	-	18,285 Added 50.0%	18,285 Common Stock

Also insider at

ITRM

Iterum Therapeutics plc Healthcare

Director

IMRA

IMARA Inc. Healthcare

Director

PYXS

Pyxis Oncology, Inc. Healthcare

GMTX

Gemini Therapeutics, Inc. Healthcare

Mark Chin

Dublin, L2

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells HARP shares.

Notify only if

Value

Insider Trading

Get notified when an Harpoon Therapeutics, Inc. insider buys or sells HARP shares.

Notify only if

Operation

Value

Type

News

Receive news related to Harpoon Therapeutics, Inc.

Track Activities on HARP

Account